Company Filing History:
Years Active: 2013
Title: Vincent Cailly-Dufestel: Innovator in Pharmaceutical Technology
Introduction
Vincent Cailly-Dufestel is a notable inventor based in Bosc-Guérard-Saint-Adrien, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations aimed at preventing misuse of medications.
Latest Patents
Cailly-Dufestel holds a patent for crush-resistant oxycodone tablets. This innovative formulation is designed to prevent accidental misuse and unlawful diversion. The water-insoluble matrix tablets are based on oxycodone or one of its pharmaceutically acceptable salts. They are capable of prolonged release of oxycodone to the body and exhibit a crush resistance of at least 4 MPa.
Career Highlights
Throughout his career, Cailly-Dufestel has worked with Ethypharm S.A. and Ethypharm, Inc. His work in these companies has focused on advancing pharmaceutical technologies and improving patient safety through innovative drug formulations.
Collaborations
Cailly-Dufestel has collaborated with professionals such as Catherine Herry and Johnatan Bacon. These partnerships have contributed to the development of his patented technologies and have enhanced the impact of his work in the pharmaceutical industry.
Conclusion
Vincent Cailly-Dufestel is a pioneering inventor whose work in creating crush-resistant oxycodone tablets showcases his commitment to improving medication safety. His contributions to the pharmaceutical field are significant and reflect his dedication to innovation.